Expression of SLC18A2 was modestly increased, but this change did not reach statistical significance (Fig. 5 G).
← all excerpts
Lidocaine inhibits hepatocellular carcinoma cell proliferation, migration, and invasion through the downregulation of SLC6A3.
1
—
—